ADVANCED MALIGNANT SOLID TUMORS
Clinical trials for ADVANCED MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo takes on advanced cancers
Disease control Not yet recruitingThis early-phase trial is testing whether two experimental drugs, SCTB41 and SCTB39G, given together every three weeks, are safe and can shrink tumors in adults with advanced solid tumors that have not responded to standard treatments. The study will enroll 112 participants acros…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Experimental injection trains immune cells inside the body to fight cancer
Disease control Not yet recruitingThis early-stage trial tests a new approach to CAR-T therapy where a virus is injected directly into the bloodstream to reprogram a patient's own immune cells to attack cancer. It involves 91 adults with advanced solid tumors who have run out of standard options. The main goal is…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy takes on advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called N-3C01, given alone or with an immunotherapy, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the right dose, and see if the combination shrinks tumors. About 114 a…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Hefei Xinzhu Biological Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for advanced cancer patients as experimental drug JSKN021 enters first human tests
Disease control Not yet recruitingThis early-stage study tests a new drug, JSKN021, in about 199 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the best dose. Researchers will also look for signs that the drug shrinks tumors…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug CS231295 enters first human trial for tough cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called CS231295 in 42 adults with advanced solid tumors that have stopped responding to standard treatments. The drug works by blocking certain proteins that help tumors grow and form blood vessels. The main goals are to check safety, find …
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: ThalassaX Therapeutics United States Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for advanced cancer: AK150 drug trial launches
Disease control Not yet recruitingThis early-stage trial tests a new drug called AK150 in about 96 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. Researchers will also look for signs that the drug shrinks tumors.
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug TPD3310 enters first human tests for advanced cancers
Disease control Not yet recruitingThis early-phase trial tests a new drug called TPD3310 in 112 people with advanced solid tumors that have not responded to standard treatments. The study aims to find a safe dose and check for early signs of tumor shrinkage. Participants receive weekly injections over 28-day cycl…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
MRNA vaccine takes on Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests a therapeutic mRNA vaccine that targets a protein called FAP found on cancer-supporting cells. The goal is to help the immune system attack the tumor's defenses. Ten adults with advanced solid tumors (like lung, colorectal, or pancreatic cancer) who h…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC